| Health / Medical Topics |
Melan-A VLP Vaccine
A vaccine consisting of the melanocyte differentiation antigen Melan A (also called MART-1) encapsulated in noninfectious virus-like particles (VLP) with potential immunostimulating and antineoplastic activities. Upon administration, Melan-A VLP vaccine may activate the immune system to exert a specific cytotoxic T lymphocyte (CTL) response against cancer cells expressing the Melan A antigen, resulting in tumor cell lysis. Melan A is an antigen that is upregulated in most melanomas. VLP stimulates the immune system and promotes the CTL response. (NCI Thesaurus)
YOU MAY ALSO LIKE
A protein found on normal melanocytes (cells that make the pigment melanin) in the skin and in the retina. It is also…
MART-1 (Melanoma Antigen Recognized by T cells, also called Melan-A) is a self antigen expressed on melanocytes and the retina. It…
The essential oil of Melaleuca quinquenervia. Melaleuca quinquenervia oil has antiseptic and antibacterial properties and is used in cosmetic products.
A tree that is a member of the myrtle family. Oil from the tea tree is used in shampoos and skin care…
A drug used alone or with dabrafenib to treat melanoma that cannot be removed by surgery or has spread to other parts…
An orally available dual inhibitor of mitogen-activated protein kinase kinase (MEK) and Aurora kinases, with potential antineoplastic activity. Upon oral administration, MEK/Aurora…
